Your browser doesn't support javascript.
loading
Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss.
Loomis, Stephanie J; Kang, Jae H; Weinreb, Robert N; Yaspan, Brian L; Cooke Bailey, Jessica N; Gaasterland, Douglas; Gaasterland, Terry; Lee, Richard K; Lichter, Paul R; Budenz, Donald L; Liu, Yutao; Realini, Tony; Friedman, David S; McCarty, Catherine A; Moroi, Sayoko E; Olson, Lana; Schuman, Joel S; Singh, Kuldev; Vollrath, Douglas; Wollstein, Gadi; Zack, Donald J; Brilliant, Murray; Sit, Arthur J; Christen, William G; Fingert, John; Kraft, Peter; Zhang, Kang; Allingham, R Rand; Pericak-Vance, Margaret A; Richards, Julia E; Hauser, Michael A; Haines, Jonathan L; Pasquale, Louis R; Wiggs, Janey L.
Afiliación
  • Loomis SJ; Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
  • Kang JH; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Weinreb RN; Department of Ophthalmology and Hamilton Glaucoma Center, University of California, San Diego, La Jolla, California.
  • Yaspan BL; Genentech, Inc., San Francisco, California.
  • Cooke Bailey JN; Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Gaasterland D; Eye Doctors of Washington, Chevy Chase, Maryland.
  • Gaasterland T; Scripps Genome Center, University of California at San Diego, La Jolla, California.
  • Lee RK; Bascom Palmer Eye Institute and Human Genomics, University of Miami Miller School of Medicine, Miami, Florida.
  • Lichter PR; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.
  • Budenz DL; Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina.
  • Liu Y; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Realini T; Department of Ophthalmology, West Virginia University Eye Institute, Morgantown, West Virginia.
  • Friedman DS; Wilmer Eye Institute, Johns Hopkins University Hospital, Baltimore, Maryland.
  • McCarty CA; Essentia Institute of Rural Health, Duluth, Minnesota.
  • Moroi SE; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.
  • Olson L; Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Schuman JS; Department of Ophthalmology, UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Singh K; Department of Ophthalmology, Stanford University, Palo Alto, California.
  • Vollrath D; Department of Genetics, Stanford University, Palo Alto, California.
  • Wollstein G; Department of Ophthalmology, UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Zack DJ; Wilmer Eye Institute, Johns Hopkins University Hospital, Baltimore, Maryland.
  • Brilliant M; Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin.
  • Sit AJ; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
  • Christen WG; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Fingert J; Departments of Ophthalmology and Anatomy/Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
  • Kraft P; Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Harvard University, Boston, Massachusetts.
  • Zhang K; Department of Ophthalmology and Hamilton Glaucoma Center, University of California, San Diego, La Jolla, California.
  • Allingham RR; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
  • Pericak-Vance MA; Bascom Palmer Eye Institute and Human Genomics, University of Miami Miller School of Medicine, Miami, Florida.
  • Richards JE; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan.
  • Hauser MA; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Haines JL; Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Pasquale LR; Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Wiggs JL; Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. Electronic address: janey_wiggs@meei.harvard.edu.
Ophthalmology ; 121(2): 508-16, 2014 Feb.
Article en En | MEDLINE | ID: mdl-24572674
ABSTRACT

PURPOSE:

The CAV1/CAV2 (caveolin 1 and caveolin 2) genomic region previously was associated with primary open-angle glaucoma (POAG), although replication among independent studies has been variable. The aim of this study was to assess the association between CAV1/CAV2 single nucleotide polymorphisms (SNPs) and POAG in a large case-control dataset and to explore associations by gender and pattern of visual field (VF) loss further.

DESIGN:

Case-control study.

PARTICIPANTS:

We analyzed 2 large POAG data sets the Glaucoma Genes and Environment (GLAUGEN) study (976 cases, 1140 controls) and the National Eye Institute Glaucoma Human Genetics Collaboration (NEIGHBOR) consortium (2132 cases, 2290 controls).

METHODS:

We studied the association between 70 SNPs located within the CAV1/CAV2 genomic region in the GLAUGEN and NEIGHBOR studies, both genotyped on the Illumina Human 660WQuadv1C BeadChip array and imputed with the Markov Chain Haplotyping algorithm using the HapMap 3 reference panel. We used logistic regression models of POAG in the overall population and separated by gender, as well as by POAG subtypes defined by type of VF defect (peripheral or paracentral). Results from GLAUGEN and NEIGHBOR were meta-analyzed, and a Bonferroni-corrected significance level of 7.7 × 10(-4) was used to account for multiple comparisons. MAIN OUTCOME

MEASURES:

Overall POAG, overall POAG by gender, and POAG subtypes defined by pattern of early VF loss.

RESULTS:

We found significant associations between 10 CAV1/CAV2 SNPs and POAG (top SNP, rs4236601; pooled P = 2.61 × 10(-7)). Of these, 9 were significant only in women (top SNP, rs4236601; pooled P = 1.59 × 10(-5)). Five of the 10 CAV1/CAV2 SNPs were associated with POAG with early paracentral VF (top SNP, rs17588172; pooled P = 1.07 × 10(-4)), and none of the 10 were associated with POAG with peripheral VF loss only or POAG among men.

CONCLUSIONS:

CAV1/CAV2 SNPs were associated significantly with POAG overall, particularly among women. Furthermore, we found an association between CAV1/CAV2 SNPs and POAG with paracentral VF defects. These data support a role for caveolin 1, caveolin 2, or both in POAG and suggest that the caveolins particularly may affect POAG pathogenesis in women and in patients with early paracentral VF defects.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos de la Visión / Campos Visuales / Glaucoma de Ángulo Abierto / Polimorfismo de Nucleótido Simple / Caveolina 1 / Caveolina 2 / Variación Estructural del Genoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos de la Visión / Campos Visuales / Glaucoma de Ángulo Abierto / Polimorfismo de Nucleótido Simple / Caveolina 1 / Caveolina 2 / Variación Estructural del Genoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article